Prof. BÜLENT YALÇIN

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment

Bardakci M., Karakas H., Bayram D., Avci N., Kitapli S., Ozen M., et al.

Scientific Reports , vol.14, no.1, 2024 (SCI-Expanded)

Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study

Sekmek S., Karahan I., Ucar G., Ceylan F., Bayram D., Seven I., et al.

Clinical and Translational Oncology , vol.26, no.8, pp.1878-1885, 2024 (SCI-Expanded)

A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review

Efil S. C., Bilgin B., Ceylan F., Karakaş H., Karahan İ., Özsan S. N., et al.

Journal of Oncology Pharmacy Practice , 2024 (SCI-Expanded)

The diurnal change of thyroid-stimulating hormone and the effect of this change on thyroid functions in patients with chronic kidney disease

Soylu H., Ersoy R., Keske P. B., Tunçay M. E., Ateş C., Çakır B., et al.

Endocrine , vol.82, no.3, pp.580-585, 2023 (SCI-Expanded)

The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)

Hizal M., Bilgin B., Paksoy N., Atcı M. M., KAHRAMAN S., Kılıçkap S., et al.

Journal of Cancer Research and Clinical Oncology , vol.149, no.8, pp.4141-4148, 2023 (SCI-Expanded)

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Chi K. N., Rathkopf D., Smith M. R., Efstathiou E., Olmos D., Lee J. Y., et al.

Journal of Clinical Oncology , vol.41, no.18, pp.3339-3351, 2023 (SCI-Expanded)

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

KAHRAMAN S., Erul E., Seyyar M., GÜMÜŞAY Ö., Bayram E., Demirel B. C., et al.

Future Oncology , vol.19, no.10, pp.727-736, 2023 (SCI-Expanded) Sustainable Development

Tamoxifen related chorioretinal structural changes

Erbahçeci Timur İ. E., Açıkgöz V., Uğurlu N., Yalçın B., ŞENDUR M. A. N., Hızal M., et al.

Cutaneous and Ocular Toxicology , vol.42, no.3, pp.109-117, 2023 (SCI-Expanded)

Do metastatic volumes measured in breast cancer patients with bone metastases correlate with the numbers of skeletal and extraskeletal events?

Yağar H., Aytekin M. N., sener dede D., Sendur M., öztürk r., yalcin b.

Joint Diseases and Related Surgery , vol.35, no.1, pp.105-111, 2023 (SCI-Expanded)

Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations

KAHRAMAN S., Bardakci M., Aykan M. B., YAŞAR S., Erol C., Hizal M., et al.

Journal of Cancer Research and Therapeutics , vol.19, no.2, pp.347-354, 2023 (SCI-Expanded)

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group

Erol C., Nahit Sendur M. A., Bilgetekin I., Garbioglu D. B., Hamdard J., Akbas S., et al.

Journal of Cancer Research and Therapeutics , vol.18, no.9, pp.347-353, 2022 (SCI-Expanded) Sustainable Development

An unusual infection with long-term bevacizumab treatment for advanced nonsmall-cell lung cancer: Actinomycosis

Erol C., Nahit Sendur M. A., YALÇIN B.

Journal of cancer research and therapeutics , vol.18, no.6, pp.1809-1810, 2022 (SCI-Expanded)

The relationship between adjuvant chemotherapy and thiol-disulfide compounds

Akyol P., Dede D., Bilgin B., Ulaş A., Nahit Şendur M. A., AKINCI M. B., et al.

Journal of Cancer Research and Therapeutics , vol.18, no.4, pp.1114-1118, 2022 (SCI-Expanded) Sustainable Development

The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study

Hizal M., Bilgin B., Paksoy N., Açıkgöz Ö., Sezer A., Gürbüz M., et al.

Journal of Cancer Research and Clinical Oncology , vol.148, no.6, pp.1501-1508, 2022 (SCI-Expanded)

Cutaneous Metastasis from Transitional Cell Carcinoma of Urinary Bladder

KALKAN G., Ahsen H., YALÇIN B.

Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.6, 2022 (SCI-Expanded)

Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?

KAHRAMAN S., Erbas U. E., YALÇIN B.

Medical Oncology , vol.39, no.3, 2022 (SCI-Expanded)

Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)

Erol C., Sakin A., Başoglu T., Özden E., ÇABUK D., Doğan M., et al.

Turkish Journal of Medical Sciences , vol.52, no.4, pp.1022-1032, 2022 (SCI-Expanded)

The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement

Bilgin B., ŞENDUR M. A. N., Yücel Ş., Hizal M., Güner G., Akyürek N., et al.

Journal of Cancer Research and Clinical Oncology , vol.147, no.9, pp.2637-2643, 2021 (SCI-Expanded) Sustainable Development

Can the host immune response against SARS-CoV2 also cause an anticancer effect?

KAHRAMAN S., AKINCI M. B., ŞENDUR M. A. N., YALÇIN B.

Medical Oncology , vol.38, no.8, 2021 (SCI-Expanded)

Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study

Bilgin B., ŞENDUR M. A. N., Yucel S., Celik E., Ozyukseler D. T., Ayhan M., et al.

Journal of Cancer Research and Clinical Oncology , vol.147, no.7, pp.2145-2152, 2021 (SCI-Expanded) Sustainable Development

Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data

Ates O., Oksuzoglu O. B., Aktas B. Y., Karadag I., Esen S., Karakaya S., et al.

Journal of B.U.ON. , vol.26, no.4, pp.1398-1404, 2021 (SCI-Expanded)

Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)

Hizal M., Sendur M. A., Yasar H. A., Bir Yucel K., Arslan C., Ucar G., et al.

Journal of Oncology Pharmacy Practice , vol.26, no.7, pp.1583-1589, 2020 (SCI-Expanded)

Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

Hizal M., Sendur M. A. N., YALÇIN B.

The New England journal of medicine , vol.383, no.7, pp.694, 2020 (SCI-Expanded)

A historical turning point for the treatment of advanced renal cell carcinoma: inhibition of immune checkpoint

HIZAL M., ŞENDUR M. A. N., BİLGİN B., AKINCI M. B., ŞENER DEDE D., YALÇIN B.

Current Medical Research and Opinion , vol.36, no.4, pp.625-635, 2020 (SCI-Expanded)

Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?

Yaman S., Bilgin B., Sendur M. A. N., Hizal M., Akinci M. B., Yalcin B.

FUTURE ONCOLOGY , vol.15, no.9, pp.925-927, 2019 (SCI-Expanded)

Prognostic effect of red cell distribution width-to-platelet ratio in colorectal cancer according to tumor stage and localization

Bilgin B., Sendur M. A. N., Hizal M., Dede D., Akinci M. B., Kandil S. U., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.15, no.1, pp.54-60, 2019 (SCI-Expanded) Sustainable Development

The results of nasopharyngeal cancer patients treated by simultaneous integrated boost technique and concomitant chemotherapy

Cetindag M. F., Ozsavran A. Y., Yalcin B., Cetindag I., Ercan K., TÜRKÖLMEZ Ş., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.2, pp.558-565, 2019 (SCI-Expanded)

Expanding treatment options for resectable gastric cancer: Is it a countdown for radiotherapy?

HIZAL M., ŞENDUR M. A. N., BİLGİN B., AKINCI M. B., Dede D., YALÇIN B.

Journal of B.U.ON. , vol.24, no.4, pp.1367-1370, 2019 (SCI-Expanded)

Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression.

Dogan H. T., Kiran M., Bilgin B., Kilicarslan A., Sendur M. A. N., Yalcin B., et al.

Diagnostic pathology , vol.13, pp.60, 2018 (SCI-Expanded)

Comparison of gemcitabine monotherapy with gemcitabine and cisplatin combination in metastatic pancreatic cancer: a retrospective analysis

Ergun Y., Ozdemir N. Y., Guner E. K., Esin E., ŞENDUR M. A. N., Koksoy E. B., et al.

JOURNAL OF BUON , vol.23, 2018 (SCI-Expanded) Sustainable Development

The current status of adjuvant treatment for high-risk renal cell carcinoma

HIZAL M., ŞENDUR M. A. N., Bilgin B., AKINCI M. B., ŞENER DEDE D., YALÇIN B.

FUTURE ONCOLOGY , vol.13, no.23, pp.2017-2020, 2017 (SCI-Expanded)

Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers

Irkkan C., Balci S., Tezel G. G., Akinci B., Yalcin B., Guler G.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.25, no.9, pp.609-614, 2017 (SCI-Expanded) Sustainable Development

Adjuvant Capecitabine for Breast Cancer

Hizal M., Sendur M. A. N., Yalcin B.

NEW ENGLAND JOURNAL OF MEDICINE , vol.377, no.8, pp.791, 2017 (SCI-Expanded) Sustainable Development

The significance of serum leptin level in patients with early stage nonsmall cell lung cancer

Karatas F., YALÇIN B., Sahin S., AKBULUT H., Utkan G., DEMİRKAZIK A., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.13, no.2, pp.204-207, 2017 (SCI-Expanded) Sustainable Development

Chemotherapy in primary osteogenic sarcoma in patients over the age of forty

Ozkurt B., Basarir K., YALÇIN B., MERTER A., YILDIZ Y., Saglik Y.

Acta Orthopaedica et Traumatologica Turcica , vol.51, no.2, pp.123-127, 2017 (SCI-Expanded)

A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer

Bilgin B., Sendur M. A. N., Dede D. S., Akinci M. B., Yalcin B.

CURRENT MEDICAL RESEARCH AND OPINION , vol.33, no.9, pp.1559-1569, 2017 (SCI-Expanded) Sustainable Development

Adding Chemotherapy After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer; Promising or not?

ŞENDUR M. A. N., BİLGİN B., AKSOY S., Akinci B., ÖZDEMİR N., Dede D. S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.27, no.3, pp.194-196, 2017 (SCI-Expanded)

Syringocystadenoma papilliferum with multiple lung metastases and long survival

Ozdemir B., Sendur M. A. N., Comert P., Yalcin B.

JOURNAL OF BUON , vol.21, no.5, pp.1324-1325, 2016 (SCI-Expanded)

Occult urinary incontinence in elderly women and its association with geriatric condition

Silay K., Akinci S., Ulas A., Yalcin A., Silay Y. S., Akinci M. B., et al.

European Review for Medical and Pharmacological Sciences , vol.20, no.3, pp.447-451, 2016 (SCI-Expanded) Sustainable Development

Thrombotic thrombocytopenic purpura following salvage chemotherapy with paclitaxel, ifosfamide and cisplatin in a patient with a refractory germ cell tumor: A case report and review of the literature

Ulas A., SILAY K., Akinci S., AKINCI M. B., ŞENDUR M. A. N., ŞENER DEDE D., et al.

ONCOLOGY LETTERS , vol.10, no.4, pp.2223-2226, 2015 (SCI-Expanded)

Radiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle invasive bladder cancer

Demirci U., Dizdar O., Cetindag M. F., Altinova S., Ozsavran A., Dede D., et al.

Journal of Cancer Research and Therapeutics , vol.11, no.4, pp.704-707, 2015 (SCI-Expanded)

Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers

Baykara M., Benekli M., EKİNCİ Ö., Irkkan S. C., Karaca H., Demirci U., et al.

JOURNAL OF GASTROINTESTINAL SURGERY , vol.19, no.9, pp.1565-1571, 2015 (SCI-Expanded) Sustainable Development

Do Statins Really Improve Colorectal Cancer-Specific Mortality?

ŞENDUR M. A. N., AKSOY S., Yalcin B.

JOURNAL OF CLINICAL ONCOLOGY , vol.33, no.7, pp.811, 2015 (SCI-Expanded) Sustainable Development

Denosumab: Excellent response of metastatic giant cell tumor of the bone

Ulas A., Akinci M. B., Silay K., Sendur M. A. N., Dede D., Yalcin B.

Journal of B.U.ON. , vol.20, no.2, pp.666-667, 2015 (SCI-Expanded)

The myth of not disclosing the diagnosis of cancer: Does it really protect elderly patients from depression?

SILAY K., Akinci S., Ulas A., Silay Y. S., AKINCI M. B., Ozturk E., et al.

Asian Pacific Journal of Cancer Prevention , vol.16, no.2, pp.837-840, 2015 (SCI-Expanded)

Primary chest wall angiosarcoma

Kabalak P. A., Demir N., YALÇIN B., CEYHAN K., KARNAK D.

Turkish Journal of Thoracic and Cardiovascular Surgery , vol.23, no.4, pp.766-769, 2015 (SCI-Expanded)

Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer

ŞENDUR M. A. N., AKSOY S., AKINCI M. B., Ozdemir N., ŞENER DEDE D., Altundag K., et al.

FUTURE ONCOLOGY , vol.11, no.6, pp.905-907, 2015 (SCI-Expanded) Sustainable Development

Actual benefit of chemo-hormonal therapy in non-castrate metastatic prostate cancer

ŞENDUR M. A. N., AKINCI M. B., Ozdemir N. Y., AKSOY S., ŞENER DEDE D., Ulas A., et al.

FUTURE ONCOLOGY , vol.11, no.8, pp.1141-1143, 2015 (SCI-Expanded) Sustainable Development

Opinions of the Turkish population on cancer and being informed of the diagnosis of cancer

YALÇIN A., SILAY K., Buyukcelik A., Isikdogan A., TÜRK H. M., COŞKUN H. Ş., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.45, no.2, pp.387-392, 2015 (SCI-Expanded)

Hospitalization risk according to geriatric assessment and laboratory parameters in elderly hematologic cancer patients

SILAY K., Akinci S., Silay Y. S., Guney T., Ulas A., AKINCI M. B., et al.

Asian Pacific Journal of Cancer Prevention , vol.16, no.2, pp.783-786, 2015 (SCI-Expanded)

Resistance to Androgen-Pathway Drugs in Prostate Cancer

ŞENDUR M. A. N., AKINCI M. B., YALÇIN B.

NEW ENGLAND JOURNAL OF MEDICINE , vol.371, no.23, pp.2233, 2014 (SCI-Expanded) Sustainable Development

End-of-study results of Turkish gastric cancer patients from the global REGATE study

YALÇIN Ş., Gumus M., KILIÇKAP S., Alkis N., Ilhan M., Oksuzoglu B., et al.

JOURNAL OF BUON , vol.19, no.2, pp.377-387, 2014 (SCI-Expanded) Sustainable Development

Substance P is a major mediator causing delayed emesis in anthracycline-based chemotherapy - Really?

Ulas A., Silay K., Akinci S., Yalcin B.

Asian Pacific Journal of Cancer Prevention , vol.15, no.24, pp.10993, 2014 (SCI-Expanded)

The relationship between common EGFR, BRAF, KRAS mutations and prognosis in advanced stage non-small cell lung cancer with response to the treatment in Turkey Türkiye'de İleri evre küçük hücreli di{dotless}şi{dotless} akciǧer kanserinde si{dotless}k görülen EGFR, BRAF, KRAS mutasyonlari{dotless}ni{dotless}n tedaviye yani{dotless}t ve prognozla İlişkisi

Dogan M., Demirkazik A., Tukun A., SAK S., CEYHAN K., YALÇIN B., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.24, no.1, pp.1-10, 2014 (SCI-Expanded)

Expectations of Response from Octreotide Therapy in Recurrent Phosphaturic Mesenchymal Tumors - Do They Reflect Reality?

Ulas A., Dede D., Sendur M. A. N., Akinci M. B., Yalcin B.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.24, pp.10997-10998, 2014 (SCI-Expanded)

Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study

Ozdemir N., Abali H., Vural M., YALÇIN Ş., Oksuzoglu B., Civelek B., et al.

Cancer Chemotherapy and Pharmacology , vol.74, no.6, pp.1139-1147, 2014 (SCI-Expanded)

Intraabdominal follicular dendritic cell sarcoma: A report of three cases and review of the literature

ÜRÜN Y., ENNELİ D., Koral L., YALÇIN B., KIRMIZI B. A., CEYHAN K., et al.

Tumori , vol.99, no.2, 2013 (SCI-Expanded)

Non-metastatic upper tract transitional cell carcinoma: Single center experience

Demirci U., Canda A. E., Dede D., Cakici O. U., AKINCI M. B., Yalcin B.

Asian Pacific Journal of Cancer Prevention , vol.14, no.2, pp.1131-1132, 2013 (SCI-Expanded)

Malign peritoneal mesothelioma with nephrotic syndrome

DOĞAN M. E., Ozal G., SAVAŞ B., Gungor M., UTKAN G., YALÇIN B., et al.

Bratislava Medical Journal , vol.113, no.1, pp.43-45, 2012 (SCI-Expanded)

Retrospective analysis of seventy-one patients with neuroendocrine tumor and review of the literature

Dogan M., YALÇIN B., Ozdemir N. Y., Arslan U. Y., Dogan L., UTKAN G., et al.

Medical Oncology , vol.29, no.3, pp.2021-2026, 2012 (SCI-Expanded)

The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis

Bozcuk H., Abali H., Coskun S., Aydiner A., Çinkaya A., Demirkazik A., et al.

World Journal of Surgical Oncology , vol.10, 2012 (SCI-Expanded)

ABO and Rh blood groups frequency in women with HER2 positive breast cancer

Urun Y., Utkan G., Altundag K., Arslan O., Onur H., Arslan U. Y., et al.

JOURNAL OF BUON , vol.17, no.3, pp.457-460, 2012 (SCI-Expanded) Sustainable Development

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

Grünwald V., Karakiewicz P. I., Bavbek S. E., Miller K., Lee S., Larkin J., et al.

European Journal of Cancer , vol.48, no.3, pp.324-332, 2012 (SCI-Expanded)

ABO and Rh Blood Groups and Risk of Colorectal Adenocarcinoma

ÜRÜN Y., Ozdemir N. Y., Utkan G., AKBULUT H., SAVAŞ B., Oksuzoglu B., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.12, pp.6097-6100, 2012 (SCI-Expanded)

Relationship between antimetabolite toxicity and pharmacogenetics in Turkish cancer patients

Dogan M., KARABULUT H. G., Tukun A., Demirkazik A., UTKAN G., YALÇIN B., et al.

Asian Pacific Journal of Cancer Prevention , vol.13, no.4, pp.1553-1556, 2012 (SCI-Expanded)

Albumin Infusion is not Beneficial in Hypoalbuminemic End-Stage Cancer Patients: A Matched-Pair Analysis

Buyukcelik A., DEMİRKAZIK A., YALÇIN B., Dogan M., KAVGACI H., Coban S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.4, pp.213-219, 2012 (SCI-Expanded)

The role of preoperative serum thyroglobulin and thyroid auto-antibody levels before histopathological diagnosis of thyroid cancers Tiroid kanserlerinin histopatolojik tanı öncesinde serum tiroglobülin ve tiroid oto-antikorları seviyelerinin rolü

Yalçin S., Ülger B. V., Parlak Ö., Uçar A. E., Sarikaya S. M., Özer M., et al.

Turkish Journal of Medical Sciences , vol.41, no.3, pp.487-493, 2011 (SCI-Expanded)

Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up)

Icli F., AKBULUT H., Onur H., YALÇIN B., Demirkazik A., Şenler F. Ç.

Breast , vol.20, no.2, pp.155-157, 2011 (SCI-Expanded)

Extranodal Hodgkin disease presenting with gluteal mass and hypercalcemia [9]

UTKAN G., Buyukcelik A., YALÇIN B., Tek I., Doruk H., Dincol D., et al.

Southern Medical Journal , vol.99, no.10, pp.1149-1150, 2006 (SCI-Expanded)

High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.

YALÇIN B., Pamir A., Büyükçelik A., UTKAN G., AKBULUT H., DEMİRKAZIK A., et al.

experimental oncology , vol.26, no.4, pp.20-25, 2004 (SCI-Expanded)

Articles Published in Other Journals

Association of Inflammatory Markers with Treatment Response in Immune Checkpoint Inhibitors

Bardakçi M., Bal Ö., Köş F. T., Demirtaş Esmer D., Hafizoğlu E., Karakaş H., et al.

Journal of Oncological Science , vol.9, no.3, pp.158-165, 2023 (Scopus)

Unresectable Hepatocellular Carcinoma and Prognostic Factors of Sorafenib Treatment: A Real-Life Experience

EROL C., Bardakçi M., Hizal M., KAHRAMAN S., Yekedüz E., Güven D. C., et al.

Journal of Oncological Science , vol.9, no.2, pp.72-78, 2023 (Scopus)

The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas Cancer

Hizal M., ŞENDUR M. A. N., Bilgin B., Karci Güner E., AKINCI M. B., Ergün Y., et al.

Journal of Oncological Science , vol.8, no.2, pp.69-75, 2022 (Scopus)

Clinical features of the ALK-mutant non-small cell lung cancer patients who received first-line alectinib treatment Birinci basamak alektinib tedavisi alan alk mutasyonu pozitif akciğer kanseri hastalarının klinik özelliklerinin değerlendirilmesi

Hizal M., Bilgin B., Şendur M. A., Yücel Ş., KAHRAMAN S., EROL C., et al.

Tuberkuloz ve Toraks , vol.69, no.3, pp.321-327, 2021 (ESCI)

The relationship between vitamin d level and disease activity in patients with rheumatoid arthritis

AKDAĞ G., ERTEN Ş., AKAN S., yanık üstüner g., KÜÇÜKŞAHİN O., YEŞİL T. H., et al.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , vol.11, 2020 (ESCI)

The association of clinicopathologic features and peripheral blood parameters with high PD-L1 expression in non-small cell lung cancer Küçük hücreli dışı akciğer kanserinde yüksek pd-l1 düzeyi ile ilişkili klinikopatolojik faktörlerin ve periferik kan parametrelerinin belirlenmesi

Bilgin B., HIZAL M., Yücel Ş., ŞENDUR M. A. N., AKYÜREK N., AKINCI M. B., et al.

Tuberkuloz ve Toraks , vol.68, no.2, pp.118-125, 2020 (ESCI)

Prognostic importance of Albumin globulin ratio in small cell lung cancer Albümin Globulin Oraninin Küçük Hücreli Akciǧer Kanserinde Prognostik Önemi

BİLGİN B., ŞENDUR M. A. N., yücel Ş., HIZAL M., YALÇIN B.

Ankara Medical Journal , vol.18, no.4, pp.729-735, 2019 (Scopus)

Following Chemotherapy: Serum Cytokine (Tumor Necrosis Factor, Interleukin-2, Interleukin-11), Immunoglobulin, Complement, Vascular Endothelial Growth Factor Levels, and the Systemic Symptoms like Capillary Leak Syndrome

KESKİN H., ÇADIRCI K., DEMİRKAZIK A., AKBULUT H., YALÇIN B.

Biomarkers in Cancer , vol.11, no.6, pp.1-9, 2019 (Peer-Reviewed Journal)

Evaluation of dynamic serum thiol-disulphide homeostasis in colorectal cancer

BİLGİN B., ŞENDUR M. A. N., HIZAL M., kandil ulutaş s., yaman s., AKINCI M. B., et al.

Journal of Oncological Sciences , 2019 (Peer-Reviewed Journal) Sustainable Development

Metastatic anal cloacogenic cell carcinoma misdiagnosed as urothelial carcinoma with long survival

BİLGİN B., YALÇIN B., ŞENDUR M. A. N., AĞAÇKIRAN Y.

Journal of Oncological Sciences , vol.3, no.2, pp.87-88, 2017 (Peer-Reviewed Journal)

The efficacy of tissue factor-603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients

Eroğlu A., Ceylan G., Ozturk E., Yalcin A., Yalcin B., Karasoy D.

Experimental Oncology , vol.38, no.3, pp.187-190, 2016 (Scopus)

Assessment of Falls in Older People Is There any Association Between Restless Leg Syndrome and Falls

SILAY K., ÖZKAYA H., yalçın a., akıncı s., ulaş a., ÖZTÜRK E., et al.

Ankara Medical Journal , vol.16, no.1, 2016 (Peer-Reviewed Journal) Sustainable Development

The Efficacy of Tıssue Factor 603A g and 5466A G Polimorphisms at the Development of Venous Thromboembolism in Cancer Patients

EROĞLU A., Ceylan G. G., Öztürk E., YALÇIN A., YALÇIN B., KARASOY D.

Experimental Oncology , vol.38, pp.187-190, 2016 (Scopus) Sustainable Development

Böbrek Hücreli Karsinomlu Hastaların Demografik Özellikleri ve Tedavi Sonuçları Tek Merkez Deneyimi Demographic Characteristics and Treatment Outcomes of Patients with Renal Cell Cancer Single Center Experience

ulaş a., BİLGİN B., ŞENER DEDE D., köş t., AKINCI M. B., ŞENDUR M. A. N., et al.

Ankara Medical Journal , 2016 (Peer-Reviewed Journal) Sustainable Development

An Independent Risk Factor for Quality of Life in Cancer Patients Urinary Incontinence

SILAY K., Sema A., BAŞTÜRK A., Ulas A., Ulusoy N., Senem M., et al.

Acta Medica Anatolia , vol.3, no.4, pp.132-136, 2015 (Peer-Reviewed Journal) Sustainable Development

The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer

ÜRÜN Y., UTKAN G., YALÇIN B., AKBULUT H., onur h., ÖZTUNA D., et al.

experimental oncology , vol.37, no.1, pp.53-57, 2015 (Scopus) Sustainable Development

Medication errors in chemotherapy preparation and administration: A survey conducted among oncology nurses in Turkey

Ulas A., Silay K., Akinci S., Dede D., AKINCI M. B., ŞENDUR M. A. N., et al.

Asian Pacific Journal of Cancer Prevention , vol.16, no.5, pp.1699-1705, 2015 (Scopus)

TÜRKİYE DE ONKOLOJİ HASTALARININ BİYOPSİKOSOSYAL VE KOZMİK İHTIYAÇLARI

SILAY K., AKINCI M. B., ARİFE U., AKINCI S., ŞENDUR M. A. N., ŞENER DEDE D., et al.

Turkiye Klinikleri Journal of Psychiatry Special Topics , vol.7, no.4, pp.1-4, 2014 (Peer-Reviewed Journal)

Staging risk assessment and screening of breast cancer

YALÇIN B.

experimental oncology , vol.35, no.4, pp.238-245, 2013 (Scopus) Sustainable Development

Overview on locally advanced breast cancer defining epidemiology and overview on neoadjuvant therapy

YALÇIN B.

experimental oncology , vol.35, no.4, pp.250-252, 2013 (Scopus) Sustainable Development

Primary Thyroid Lymphoma Diagnosed During Pregnancy A Case Report

Demir Önal E., Polat Ş. B., Korkmaz M. H., Yalçın B., Köybaşıoğlu F., Ersoy R., et al.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , vol.17, no.2, pp.49-51, 2013 (Scopus)

Levels of trace elements and toxic metals in autopsy renal tissue samples Otopsi böbrek dokusu örneklerinde iz element ve toksik metal düzeylerinin deǧerlendirilmesi

Yilmaz H., TÜRKSOY V. A., Kayaalti Z., YALÇIN B., Söylemezoǧlu T.

Turkiye Klinikleri Journal of Medical Sciences , vol.32, no.1, pp.7-14, 2012 (Scopus)

Kikuchi - Fujimoto disease: Cervical lymphadenopathy suggestive of relapsing lymphoma in patient with lymphoblastic lymphoma

ÜRÜN Y., UTKAN G., ENNELİ D., DOĞAN M. E., YALÇIN B., Icli F.

Experimental Oncology , vol.33, no.4, pp.242-244, 2011 (Scopus)

Two cases with atypical metastasis in colorectal cancer splenic and renal metastasis

dogan m., ozal f. g., ekinci c., UTKAN G., ÜRÜN Y., YALÇIN B., et al.

experimental oncology , vol.32, no.4, pp.277-279, 2010 (Scopus) Sustainable Development

A metastasis of colorectal cancer to the thyroid gland which has also papillary thyroid cancer: A case report

YALÇIN A., ÜNAL A. E., BAYAR S., YALÇIN B.

Turkish J Cancer , 2008 (Peer-Reviewed Journal) Sustainable Development

Pseudomyxoma peritonei: What Do We Have?

YALÇIN A., ERGÜL E., KORUKLUOĞLU B., YALÇIN B.

The Internet Journal of Surgery , 2008 (Peer-Reviewed Journal)

Refereed Congress / Symposium Publications in Proceedings

PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY)

EROL C., HIZAL M., BİLGETEKİN İ., AKBAŞ S., GARİPOĞLU D. B., HAMDARD J., et al.

10. INTERNATIONAL GASTROINTESTINAL CANCER CONFERENCE, Turkey, 2 - 06 December 2020, pp.40-41

EFFICACY AND SAFETY OF FOLFIRI/AFLIBERCEPT IN PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER PATIENTS (TOG STUDY)

EROL C., HIZAL M., BİLGETEKİN İ., akbaş s., ŞENER DEDE D., AKINCI M. B., et al.

10TH International Gastrointestinal Cancers Virtual Conference, Online, Turkey, 2 - 06 December 2020, pp.39-40

PROGNOSTIC AND PREDICTIVE MARKERS OF FOLFIRI/AFLIBERCEPT IN PATIENTS WITH METASTATIC COLORECTAL CANCER (TOG STUDY) Cihan Erol1 , Mutlu Hızal2 , Irem Bilgetekin3 , Sinem Akbas4 , Duygu Bayir Garbioglu5 , Jamshid Hamdard6 , Cagatay Arslan7 , Alper Sevinc8 , Ahmet Kucukarda9 , Dilek Gurgenyatagi10, Emre Cakir11, Aykut Demirkiran12, Murat Araz12, Sercan On13, Izzet Dogan14, Atike Pinar Erdogan15, Sinan Koca16, Pinar Kubilay17, Onder Eren18, Deniz Tataroglu Ozyukseler19, Mahmut Emre Yildirim19, Ebru Cilbir20, Emir Celik21, Aykut Bahceci22, Halil Taskaynatan23, Abdulkerim Oyman24, Gulhan Ipek Deniz25, Serkan Menenekse26, Engin Kut26, Ahmet Gulmez27, Abdullah Sakin28, Erdinc Nayir29, Ramazan Acar30, Seda Kahraman1 , Erdem Sen31, Ali Inal32, Serdar Turhal33, Ali Osman Kaya34, Semra Paydas35, Didem Tastekin14, Ilhan Hacıbekiroglu11, Irfan Cicin9 , Ahmet Bilici6 , Didem Sener Dede1 , Muhammed Bulent Akinci1 , Nil Molinas Mandel36, Berna Oksuzoglu3 , Dogan Uncu2 , Bulent Yalcin1 , Mehmet Artac12, Mehmet Ali Nahit Sendur1

EROL C., HIZAL M., BİLGETEKİN İ., akbaş s., ÇİÇİN İ., ŞENER DEDE D., et al.

10TH International Gastrointestinal Cancers Virtual Conference, Turkey, 02 December 2020

THE INCIDENCE AND PROGNOSTIC SIGNIFICANCE OF SARCOPENIA IN ADVANCED GASTRIC CANCER PATIENTS

GÜMÜŞÇUBUK O., HIZAL M., BİLGİN B., AKINCI M. B., YALÇIN B., ŞENER DEDE D., et al.

10TH International Gastrointestinal Cancers Virtual Conference, Turkey, 02 December 2020

The incidence and prognostıc significance of sarcopenia in advanced gastric cancer patients

GÜMÜŞÇUBUK O., HIZAL M., BİLGİN B., AKINCI M. B., YALÇIN B., ŞENER DEDE D., et al.

10th International Gastrointestinal Cancer Conference, 2-6 December 2020., Turkey, 2 - 06 December 2020

The investigation of the related factors that affected targeted therapy outcome in metastatic colon cancer

TUTUM Ş., BİLGİN B., HIZAL M., AKINCI M. B., YALÇIN B., ŞENDUR M. A. N.

10th International Gastrointestinal Cancer Conference, 2-6 December 2020., Turkey, 02 December 2020

MALİGN GLİAL TÜMÖRLERİN KLİNİKOPATOLOJİK ÖZELLİKLERİ VE SAĞKALIM VERİLERİNİN İNCELENMESİ

Aşan B., TATLI DOĞAN H., ERCAN K., BAŞER S., ŞENDUR M. A. N., AKINCI M. B., et al.

4th İnternational Hippocrates Congress on Medical and Health Science, Turkey, 25 - 16 September 2020

Malign Glial Tümörlerin Klinikopatolojik Özellikleri ve Sağkalim Verilerinin İncelenmesi

asan f. b., TATLI DOĞAN H., ERCAN K., BAŞER S., ŞENDUR M. A. N., AKINCI M. B., et al.

4. Uluslararası Hipokrat Tıp ve Sağlık Bilimleri Kongresi 25-26 Eylül 2020 Antalya, Türkiye, Antalya, Turkey, 25 September 2020, pp.925-932

Determination of the Prognostic Markers Before Second line Treatment in Metastatic Pancreas Cancer

BİLGİN B., ŞENDUR M. A. N., KARCI GÜNER E., HIZAL M., ERGÜN Y., ESİN E., et al.

8th International Gastrointestinal Cancer Conference, İstanbul, Turkey, 7 - 09 December 2018 Sustainable Development

Efficacy of The Second-line Treatment in Metastatic Pancreas Cancer

ŞENDUR M. A. N., BİLGİN B., KARCI GÜNER E., HIZAL M., ERGÜN Y., ESİN E., et al.

8th International Gastrointestinal Cancer Conference, İstanbul, Turkey, 7 - 09 December 2018 Sustainable Development

The Effect of Sarcopenia on Acute Chemotherapy Toxicity in Gastrointestinal Cancer Patients Undergoing Systemic Therapy

ÖZDEMİR N., ŞENDUR M. A. N., ZENGİN N., YALÇIN B., ŞENER DEDE D., Yazıcı O., et al.

ESMO 2018 Congress, 19 - 23 October 2018 Sustainable Development

The effectt of sarcopenia on acute chemotherapy toxicity in gasrtointestinal cancer patients undergoing systemic therapy

ÖZDEMİR N., YAZICI O., SILAY K., uçar g., eren t., ŞENER DEDE D., et al.

esmo 2018, 19 - 23 October 2018 Sustainable Development

Metastatik Pankreas Kanserinde 1. Basamakta Gemsitabin ile Gemsitabin ve Sisplatin Kombinasyonunun Karşılaştırması: Çok Merkezli Retrospektif Analiz

ERGÜN Y., ÖZDEMİR N., KARCI GÜNER E., ESİN E., ŞENDUR M. A. N., KÖKSOY E. B., et al.

Sağlık Bilimleri Üniversitesi İç Hastalıkları Kongresi, İstanbul, Turkey, 27 - 30 June 2018

Independent prognostic value of inflammation in metastatic pancreatic cancer.

ESİN E., ÇAKMAK ÖKSÜZOĞLU Ö. B., KÖKSOY E. B., DEMİRCİ N. S., ŞENDUR M. A. N., DEDE İ., et al.

JOURNAL OF CLINICAL ONCOLOGY, 1 - 05 June 2018, vol.36 Sustainable Development

Bilateral adrenalectomy for occult ectopic Cushing’s syndrome in twopatients with catastrophic hypercortisolism

TOPALOĞLU O., beştepe n., YALÇIN B., KILIÇ M., rusen metin m., UÇMAK G., et al.

europen congress of endocrinology, 19 - 22 May 2018

Metastatik Pankreas Kanserinde İkinci Basamak Tedavi Öncesi Prognostik Belirteçlerin Saptanması

BİLGİN B., ŞENDUR M. A. N., KARCI GÜNER E., ERGÜN Y., ESİN E., KÖKSOY E. B., et al.

7. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2018 Sustainable Development

Metastatik Pankreas Kanserinde 2. Basamak Tedavilerin Etkinliği

ŞENDUR M. A. N., BİLGİN B., KARCI GÜNER E., ERGÜN Y., ESİN E., KÖKSOY E. B., et al.

7. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2018 Sustainable Development

Pankreas Kanseri ve ABO Kan Grubu İliskisi: Çok Merkezli, Gözlemsel, Vaka-Kontrol Çalışması

KÖKSOY E. B., UTKAN G., ERGÜN Y., ESİN E., ŞENDUR M. A. N., KARCI GÜNER E., et al.

7. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2018 Sustainable Development

The Role of Dynamic Serum Thiol-Disulphide Homeostasis in Metastatic Gastric Cancer

BİLGİN B., ŞENDUR M. A. N., HIZAL M., AKINCI M. B., DEDE D. Ş., YAMAN S., et al.

7TH INTERNATIONAL GASTROINTESTINAL CANCERS CONFERENCE, İstanbul, Turkey, 15 - 17 December 2017 Sustainable Development

Evaluation of dynamic serum thiol disulphide homeostasis in colorectal cancer

BİLGİN B., ŞENDUR M. A. N., HIZAL M., AKINCI M. B., ŞENER DEDE D., Yaman S., et al.

7th International Gastrointestinal Cancers Conference, 15 - 17 December 2017 Sustainable Development

İleri yaş gastroenteropatik nöroendokrin tümörlerde sağkalımda etkili faktörler

TAHTACI M., kılıç g. s., POLAT Y. H., TATLI DOĞAN H., METİN M. R., TÜRKÖLMEZ Ş., et al.

34.ulusal gastroenteroloji haftası, Turkey, 1 - 06 December 2017

İleri yaş gastroenteropankreatik nöroendokrin tumörlerde sağkalımda etkili faktörler (Ankara Yıldırım Beyazıt Universitesi GEP-NET grup)

TAHTACI M., KILIÇ G. S., POLAT Y. H., TATLI DOĞAN H., RUSEN METİN M., TÜRKÖLMEZ Ş., et al.

34. ULUSAL GASTROENTEROLOJİ HAFTASI, Turkey, 1 - 06 December 2017

İleri yaş gastroenteropankreatik tümörlerde sağkalımda etkili faktörler (Ankara Yıldırım Beyazıt Üniversitesi GEP-NET grup)

TAHTACI M., kılıç G. s., POLAT Y. H., metin ruşen m., TATLI DOĞAN H., TÜRKÖLMEZ Ş., et al.

34.ulusal gastroenteroloji haftası, Turkey, 1 - 06 December 2017

The association and prognostic significance of programmed death-ligand 1 (PD-L1) and isocitrate dehydrogenase (IDH-1) mutation in glioblastome multiforme(GBM) patients.

ŞENER DEDE D., TATLI DOĞAN H., Asan F. B., GÜMÜŞKAYA ÖCAL B., Ayık S., ŞENDUR M. A. N., et al.

2017 ASCO Annual Meeting. J Clin Oncol 35, 2017 (suppl abstr e13536), 2 - 06 June 2017

Panhipopitüitarizmin nadir bir nedeni: meme kanseri metastazı

ÖZDEMİR D., BİLGİNER M. C., AKINCI M. B., YALÇIN B., KARAKÖK E., ERSOY R., et al.

39. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Turkey, 3 - 07 May 2017 Sustainable Development

t790M MutaSyonu pozitiF akciğER kanSERindE oSiMERtiniB diREnci; olgu SunuMu

BİLGİN B., ŞENDUR M. A. N., HIZAL M., ŞENER DEDE D., AKINCI M. B., SILAY K., et al.

22. ULUSAL KANSER KONGRESİ, Turkey, 19 - 23 April 2017 Sustainable Development

ilERi EvRE koloREktal kanSERlERdE RdW-platElEt oRanInIn pRognoStik önEMi

BİLGİN B., HIZAL M., ŞENDUR M. A. N., AKINCI M. B., YAMAN S., ULUTAŞ KANDİL S., et al.

22. ULUSAL KANSER KONGRESİ, Turkey, 19 - 23 April 2017 Sustainable Development

Metastatik Olmayan KolorektalAdenokanserlerde Lenf NoduMetastazı İçin Prediktif Faktörlerin Değerlendirilmesi

karcı E., KÖKSOY E. B., Hocazade C., BİLGİN B., ALKAN A., tuncay G., et al.

22. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2017

ERkEn EvRE koloREktal kanSERlERdE RdW-platElEt oRanInIn pRognoStik önEMi

BİLGİN B., HIZAL M., AKINCI M. B., ŞENDUR M. A. N., ŞENER DEDE D., ÖZDEMİR N., et al.

22. ULUSAL KANSER KONGRESİ, Turkey, 19 - 23 April 2017 Sustainable Development

2016 yIlInda tÜRkiyE kaynaklI onkolojik yayInlaR

ŞENDUR M. A. N., BİLGİN B., HIZAL M., ÖZDEMİR N., AKINCI M. B., ŞENER DEDE D., et al.

22. ULUSAL KANSER KONGRESİ, Turkey, 19 - 23 April 2017

Prognostıc importance red cell dısturbatıon wıdth to platelet ratio in advanced colorectal cancer

BİLGİN B., HIZAL M., ŞENDUR M. A. N., AKINCI M. B., YAMAN S., ULUTAŞ S. K., et al.

6th international Gastrointestinal cancer conferance December 2016 Antalya, Turkey, 2 November - 06 December 2016 Sustainable Development

THE PROGNOSTIC FACTORS IN STAGE 3 COLORECTAL CANCER PATIENTS

HIZAL M., BİLGİN B., ŞENDUR M. A. N., AKINCI M. B., ŞENER DEDE D., Yaman S., et al.

6th InternatIonalGastroIntestInal CanCerConferenCe, 2 - 04 December 2016 Sustainable Development

THE NEUTROPHIL LYMPHOC YTE RATIO MAY HAVE PROGNOSTICEFFECT IN THE METASTATIC COLORECTAL CANCER

HIZAL M., BİLGİN B., ŞENDUR M. A. N., Dede D. Ş., AKINCI M. B., Kandil S. U., et al.

6th InternatIonalGastroIntestInal CanCerConferenCe, 2 - 04 December 2016 Sustainable Development

PROGNOSTIC IMPORTANCE RED CELL DISTURBATION WIDTH TOPLATELET RATIO IN ADVANCED COLORECTAL CANCER

BİLGİN B., HIZAL M., ŞENDUR M. A. N., AKINCI M. B., Yaman S., Kandil S. u., et al.

6th InternatIonalGastroIntestInal CanCerConferenCe, 2 - 04 December 2016 Sustainable Development

METASTATIC COLORECTAL CANCER SURVIVAL IS THERE A DIFFERENCEBETWEEN SYNCHRONOUS OR METACHRONOUS TUMORS

HIZAL M., BİLGİN B., ŞENDUR M. A. N., Dede D. Ş., AKINCI M. B., Yaman s., et al.

6th International Gastrointestinal Cancers Conference, 2 - 04 December 2016 Sustainable Development

EFFECT OF THE RAS STATUS ON SURVIVAL IN ADVANCED COLON CANCER

BİLGİN B., HIZAL M., ŞENDUR M. A. N., Kandil S. U., Yaman S., AKINCI M. B., et al.

6th InternatIonal GastroIntestInal CanCer ConferenCe, 2 - 04 December 2016 Sustainable Development

A rare case metastatic anal cloacogenic transitional cell carcinoma

BİLGİN B., HIZAL M., ŞENDUR M. A. N., AKINCI M. B., Yaman S., Ulutaş Kandil S., et al.

6th International Gastrointestinal Cancers Conference, 2 - 04 December 2016

Association between tumor localisation and clinicopathological characteristics and survival of colorectal cancer

BİLGİN B., HIZAL M., ŞENDUR M. A. N., ŞENER DEDE D., AKINCI M. B., yaman S., et al.

th International Gastrointestinal Cancers Conference, 2 - 04 December 2016 Sustainable Development

Compare tumor features and survival in right sided and left sided early stage colorectal cancer

BİLGİN B., HIZAL M., ŞENDUR M. A. N., ŞENER DEDE D., AKINCI M. B., ÖZDEMİR N., et al.

6th International Gastrointestinal Cancers Conference, 2 - 04 December 2016 Sustainable Development

ASSOSCIATION BETWEEN TUMOR LOCALISATION AND CLINICOPATHOLOGICAL CHARACTERISTICS AND SURVIVAL OF COLORECTAL CANCER

BİLGİN B., HIZAL M., ŞENDUR M. A. N., ŞENER DEDE D., AKINCI M. B., yaman s., et al.

6,International gastrointestinal cancer confrence, 2 - 04 December 2016 Sustainable Development

ASSESSMENT OF THE COST EFFECTIVENESS OF THE FIRST LINE TARGETED THERAPIES FOR ADVANCED COLON CANCER IN TURKEY

BİLGİN B., HIZAL M., ŞENDUR M. A. N., ŞENER DEDE D., ulutaş kandil s., yaman s., et al.

6,International gastrointestinal cancer confrence, 2 - 04 December 2016 Sustainable Development

Effects of neutrophil lymphocyte ratio and platelet lymphocyte ratio on survival of non metastatic colorectal cancer

HIZAL M., BİLGİN B., ŞENDUR M. A. N., AKINCI M. B., ŞENER DEDE D., Ulutaş Kandil S., et al.

6th International Gastrointestinal Cancers Conference, 2 - 04 December 2016 Sustainable Development

Metastatic colorectal cancer survival İs there a difference between synchronous or metachronous tumors

HIZAL M., BİLGİN B., ŞENDUR M. A. N., ŞENER DEDE D., AKINCI M. B., yaman s., et al.

6th International Gastrointestinal Cancers Conference, 2 - 04 December 2016 Sustainable Development

Gastric cancer with lung metastasis and concurrent miliary tuberculosis

HIZAL M., BİLGİN B., ŞENDUR M. A. N., AKINCI M. B., ŞENER DEDE D., YALÇIN B.

6th International Gastrointestinal Cancers Conference, 2 - 04 December 2016 Sustainable Development

Effect of using different antihypertensive drugs ondemographic and clinico pathological characteristics ofbreast cancerM A Sendur1 S Aksoy2 N Ozdemir1 O Yazici3 M B Akıncı1 D S Dede1 B Yalçın1 N Zengin1 K Altundag2

ŞENDUR M. A. N., AKSOY S., ÖZDEMİR N., YAZICI O., AKINCI M. B., ŞENER DEDE D., et al.

ESMO, 7 - 11 November 2016 Sustainable Development

Hodgkin lenfomada PD-1, PD-L1 eksresyonunun EBV (Ebstein Barr Virus) ile ilişkisi ve prognostik önemi

ÖZTÜRK V., TATLI DOĞAN H., BALCI S., SÜNGÜ N., BAKANAY ÖZTÜRK Ş. M., ŞENTÜRK YIKILMAZ A., et al.

26. Ulusal Patoloji 7. Ulusal Sitopatoloji Kongesi, Turkey, 2 - 06 November 2016

Effect of red cell disturbatıon width to platelet ratio on dısease free survival in early stage colorectal cancer

BİLGİN B., HIZAL M., AKINCI M. B., ŞENDUR M. A. N., ŞENER DEDE D., ÖZDEMİR N., et al.

6th international Gastrointestinal cancer conferance December 2016 Antalya, Turkey, 2 - 06 November 2016 Sustainable Development

HODGKİN LENFOMADA PD-1, PD-L1EKSPRESYONUNUN EBV(EPSTEİN-BARR VİRUS)İLE İLİŞKİSİ VE PROGNOSTİK ÖNEMİ

öztürk v., TATLI DOĞAN H., BALCI S., SÜNGÜ N., BAKANAY ÖZTÜRK Ş. M., ŞENTÜRK YIKILMAZ A., et al.

26. ULUSAL PATOLOJİ 7. ULUSAL SİTOPATOLOJİ KONGRESİ, Turkey, 2 - 06 November 2016

Association between tumor localisation andClinicopathologic characteristics and survival of colorectal cancer

BİLGİN B., HIZAL M., ŞENDUR M. A. N., ŞENER DEDE D., AKINCI M. B., YAMAN S., et al.

6th international Gastrointestinal cancer conferance December 2016 Antalya, Turkey, 2 - 06 November 2016 Sustainable Development

Efficacy of statin usage before diagnosis on clinico pathological characteristics and outcome of invasive breast cancer Annals of Oncology

ŞENDUR M. A. N., AKSOY S., ÖZDEMİR N., yazıcı o., YALÇIN B., ZENGİN N., et al.

41st ESMO Congress (ESMO 2016), 7 - 11 October 2016 Sustainable Development

METASTATİK KOLON KANSERİ HASTALARINDA BİRİNCİ BASAMAK HEDEFE YÖNELİK TEDAVİLERİN MALİYET ANALİZİ

BİLGİN B., ŞENDUR M. A. N., AKINCI M. B., ULAŞ A., YAMAN S., BAŞER S., et al.

6. Türk Tıbbi Onkoloji Kongresi, Turkey, 23 - 27 March 2016

METASTATİK MALİGN MELANOMDA BİRİNCİ BASAMAK TEDAVİLERİN MALİYET ANALİZİ

BİLGİN B., ŞENDUR M. A. N., AKINCI M. B., ŞENER DEDE D., ULAŞ A., YAMAN S., et al.

6. Türk Tıbbi Onkoloji Kongresi, Turkey, 23 - 27 March 2016

The ef cacy and predictive factors of response of second line triplet modi ed EOX epirubicin oxaliplatin capacitabine regimen in metastatic gastric cancer

ŞENDUR M. A. N., ÖZDEMİR N., AKSOY S., yazıcı o., yazılıtaş d., AKINCI M. B., et al.

ESMO European Cancer Congress, 25 - 29 September 2015 Sustainable Development

Turkish National Breast Cancer Registry

ALTUNDAĞ M. K., dumanlı e., aliustaoğlu m., uncu d., ÖZKAN M., ÇİÇİN İ., et al.

asco annual meeting, 30 May - 03 June 2015 Sustainable Development

Association of obesity with breast cancer clinical and pathological factors Analysis of Turkish National Breast Cancer Registry

COŞKUN U., ALTUNDAĞ M. K., aliustaoğlu m., uncu d., ÖZKAN M., ÇİÇİN İ., et al.

asco annual meeting, 30 May - 03 June 2015 Sustainable Development

Tissue Factor Gene 603A G and 5466A G polymorphisms are not Associated with Venous Thromboembolism in Cancer Patients

EROĞLU A., GÜLEÇ CEYLAN G., öztürk e., KARASOY D., YALÇIN A., YALÇIN B., et al.

Congress on Controversies in Thrombosis&Hemostasis, 30 October - 01 November 2014 Sustainable Development

The Prevalence and Clinical Signi cance of Serum Anti Cyclic Citrullinated Peptide Antibodies in Primary Sjögren s Syndrome

AKTAN KÖŞKER T., ERTEN Ş., KÜÇÜKŞAHİN O., ALTUNOĞLU A., UZ E., YALÇIN B.

Mediterranean Congress of Rheumatology, 28 - 31 August 2014

ASSESSMENT OF GERIATRIC SYNDROMES AND FUNCTIONAL STATUS IN ELDERLY HEMATOLOGIC CANCER PATIENTS IN TURKEY

SILAY K., AKINCI M. B., GÜNEY T., ÖZTÜRK E., CANBAZ M., YALÇIN B., et al.

19TH EHA (EUROPEAN HEMATOLOGY ASSOCIATION) CONGRESS 2014, 15 June 2014 Sustainable Development

Kronik Böbrek Hastalarında Serum Tiroid Uyaran Hormon’un (TSH) Diurnal Değişimi ve Bu Değişimin Tiroid Fonksiyonları Üzerine Etkisi

SOYLU H., ERSOY R., BAL KESKE P., ERGİN M., ATEŞ C., ÇAKIR B., et al.

36. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Turkey, 21 May 2014

Primary tyhroid lymphoma Diagnosed during Pregnancy Report of a Case

DEMİR ÖNAL E., POLAT Ş. B., KORKMAZ M. H., YALÇIN B., KÖYBAŞIOĞLU F., ERSOY R., et al.

15 th International & 14 th European Congress of Endocrinology, 5 - 09 May 2012

Gebelikte tiroidte ani büyüme ve bası semptomları ile kendini gösteren agresif B hücreli nonhodgkin lenfoma

DEMİR ÖNAL E., POLAT Ş. B., KORKMAZ M. H., YALÇIN B., KÖYBAŞIOĞLU F., ERSOY R., et al.

33. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Turkey, 12 - 16 October 2011

FLOW CYTOMETRY COMBINED WITH FINE NEEDLE ASPIRATION BIOPSY IS ESSENTIAL FOR DIAGNOSIS OF A RAPIDLY GROWING THYROID GLAND

EVRANOS B., AĞBAHT K., Atlı T., YALÇIN B., ERDOĞAN M. F.

34th Annual Meeting of the European Thyroid Association, 5 - 09 September 2009

Metrics

Publication

162

Citation (Scopus)

540

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citiation (TrDizin)

H-Index (TrDizin)

Project

Open Access

UN Sustainable Development Goals

Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings